IL139339A0 - The induction of antibiotic peptides by lait (scd14) protein - Google Patents

The induction of antibiotic peptides by lait (scd14) protein

Info

Publication number
IL139339A0
IL139339A0 IL13933999A IL13933999A IL139339A0 IL 139339 A0 IL139339 A0 IL 139339A0 IL 13933999 A IL13933999 A IL 13933999A IL 13933999 A IL13933999 A IL 13933999A IL 139339 A0 IL139339 A0 IL 139339A0
Authority
IL
Israel
Prior art keywords
scd14
lait
induction
protein
antibiotic peptides
Prior art date
Application number
IL13933999A
Other languages
English (en)
Original Assignee
Gemma Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemma Biotechnology Ltd filed Critical Gemma Biotechnology Ltd
Publication of IL139339A0 publication Critical patent/IL139339A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13933999A 1998-05-27 1999-05-27 The induction of antibiotic peptides by lait (scd14) protein IL139339A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8688498P 1998-05-27 1998-05-27
PCT/CA1999/000482 WO1999061468A2 (fr) 1998-05-27 1999-05-27 INDUCTION DE PROTEINES ET DE PEPTIDES ANTIBIOTIQUES AU MOYEN DE LA PROTEINE sCD14/LAIT (PROTEINE IMMUNOTROPHIQUE ASSOCIEE A LA LACTATION)

Publications (1)

Publication Number Publication Date
IL139339A0 true IL139339A0 (en) 2001-11-25

Family

ID=22201526

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13933999A IL139339A0 (en) 1998-05-27 1999-05-27 The induction of antibiotic peptides by lait (scd14) protein

Country Status (14)

Country Link
US (1) US7592310B2 (fr)
EP (1) EP1080111B1 (fr)
JP (1) JP2002516339A (fr)
CN (1) CN1322214A (fr)
AU (1) AU771448B2 (fr)
BR (1) BR9910725A (fr)
CA (1) CA2328134A1 (fr)
CZ (1) CZ20004256A3 (fr)
HK (1) HK1041892A1 (fr)
HU (1) HUP0101987A3 (fr)
ID (1) ID26730A (fr)
IL (1) IL139339A0 (fr)
PL (1) PL345208A1 (fr)
WO (1) WO1999061468A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022945A2 (fr) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Proteine pour le traitement ou la prevention d'un trouble de la voie gastro-intestinale
AU2001244711A1 (en) * 2000-03-31 2001-10-08 Mochida Pharmaceutical Co., Ltd. Tlr/cd14 binding inhibitor
CA2524534C (fr) 2003-05-15 2012-12-11 Sek Chung Fung Procedes et compositions pour la prevention et le traitement de la sepsie
CA2566101C (fr) * 2004-05-11 2013-05-21 Mochida Pharmaceutical Co., Ltd. Nouvel antigene cd14 soluble
WO2009095916A2 (fr) * 2008-01-29 2009-08-06 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Cd14 et peptides de celui-ci pour la protection de cellules contre la mort cellulaire
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
EA024697B1 (ru) 2009-04-27 2016-10-31 Иммурон Лимитед Применение композиции, содержащей обогащенный анти-lps-антителами иммуноглобулиновый препарат, для лечения заболеваний печени
US9943597B2 (en) 2010-08-17 2018-04-17 Immuron Limited Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
RU2723554C2 (ru) * 2011-05-19 2020-06-16 Мотида Фармасьютикал Ко., Лтд. Диагностика инфекционного заболевания дыхательных путей с использованием образцов крови

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
WO1991001639A1 (fr) * 1989-08-01 1991-02-21 Scripps Clinic And Research Foundation Procedes et compositions ameliorant les symptomes de la septicemie
CA2133758A1 (fr) * 1992-04-06 1993-10-14 Sanna M. Goyert Nouveau mode de traitement de la septicemie utilisant une forme soluble d'antigene myelomonocytaire cd14 recombinant
WO1994028025A1 (fr) * 1993-05-28 1994-12-08 The Scripps Research Institute Procedes et compositions d'inhibition de l'activation des cellules induites par cd14
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
CA2208699A1 (fr) * 1994-12-30 1996-07-11 Rockefeller University (The) Polypeptides cd14 anti-inflammatoires
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
AU5688596A (en) 1995-04-13 1996-10-30 Deutsche Om Arzneimittel Gmbh Anti-cd14 antibodies for use in the induction of il-10 secre tion
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
EP1080111A2 (fr) 2001-03-07
CZ20004256A3 (cs) 2001-09-12
US20040259795A1 (en) 2004-12-23
WO1999061468A2 (fr) 1999-12-02
AU4025899A (en) 1999-12-13
US7592310B2 (en) 2009-09-22
JP2002516339A (ja) 2002-06-04
HK1041892A1 (zh) 2002-07-26
HUP0101987A3 (en) 2010-01-28
AU771448B2 (en) 2004-03-25
ID26730A (id) 2001-02-01
PL345208A1 (en) 2001-12-03
HUP0101987A2 (hu) 2001-09-28
EP1080111B1 (fr) 2012-07-25
CN1322214A (zh) 2001-11-14
WO1999061468A3 (fr) 2000-04-06
CA2328134A1 (fr) 1999-12-02
BR9910725A (pt) 2001-01-30

Similar Documents

Publication Publication Date Title
AU1550300A (en) Antigen-binding proteins
EP1110969A4 (fr) Proteine de liaison de l'interleukine 18
HK1039158A1 (zh) Nlk1相互作用蛋白
HUP0101987A3 (en) The induction of antibiotic peptides by lait (scd14) protein
EP1103604A4 (fr) Nouveau polypeptide
AU1744900A (en) Gtpase associated proteins
IL143052A0 (en) Mammalian chondromodulin-like protein
AU2452301A (en) Protein methylarginine-specific antibodies
PL344979A1 (en) Angiostatin-binding protein
GB9818915D0 (en) Antibodies
GB9828704D0 (en) Proteins
GB9816337D0 (en) Proteins
GB9828880D0 (en) Protein
GB9819411D0 (en) Antibodies
GB9827845D0 (en) Immunoassay or proteins
GB9808423D0 (en) Bacterial polypeptide family
GB9808350D0 (en) Bacterial polypeptide family
EP1127066A4 (fr) Proteines modifiees
GB9809566D0 (en) Protein
GB9819038D0 (en) Protein
GB9805792D0 (en) Bacterial polypeptide family
GB9808363D0 (en) Bacterial polypeptide family
GB0315759D0 (en) Proteins
GB9816336D0 (en) Proteins
GB9816335D0 (en) Proteins